Oseltamivir vs Influenza Virus Vaccine (Live/Attenuated)

Interacting Drugs
Oseltamivir
vs
Influenza Virus Vaccine (Live/Attenuated)
Security Level
Moderate, Consider therapy modification
Mechanism
Influenza Virus Vaccine (Live/Attenuated): Antiviral Agents (Influenza A and B) may diminish the therapeutic effect of Influenza Virus Vaccine (Live/Attenuated).
Management
Avoid anti-influenza antivirals during the period beginning 48 hours prior to and ending 2 weeks after vaccine administration. Persons receiving these agents within 2 weeks of the live intranasal spray vaccine should receive a repeat vaccine dose.

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Oseltamivir vs Influenza Virus Vaccine (Live/Attenuated)